Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREArtificial intelligence is accelerating opportunities. Realizing the benefits for healthcare requires the right expertise. Together, we can solve the problems of today, and drive the breakthroughs of tomorrow.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREIQVIA enables genomic research via global access to a network of genomic-clinical data, proprietary technologies that enable federated analytics, and therapeutic area & bioinformatics expertise to help you answer your most pressing research questions.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSAs the pharmaceutical industry turns to ever more sophisticated specialty treatments for highly defined, often very small patient populations, competition intensifies and payer tensions grow. The return on innovative launches has not kept pace with rising clinical development costs.
The pharmaceutical industry is in both the best and worst of times. The industry is in a golden age of pipeline productivity – but as the focus turns to ever more sophisticated specialty treatments for highly defined, often very small patient populations, competition intensifies and payer tensions grow. The countries driving most of the industry’s return on innovation see budgetary challenge, rebate and discount growth and increased risk.
Profitability has reduced, and the return on innovative launches has not kept pace with rising clinical development costs. Portfolios see faster, and more extensive, value erosion post loss of exclusivity as biologics experience low-cost competition. Technology has hugely improved the availability of data to understand patients and conditions better, to demonstrate the value of new medicines and to guide pharma decision making. But often, companies struggle to make the best use possible of this data.
The pharmaceutical industry is in a revolutionary period of innovation. Advances in understanding the genomics of disease, and in the personalisation of treatment, have been augmented by the introduction of regenerative medicine platforms, where gene and cell therapies offer curative approaches to serious, often life limiting, disease. If these technologies fulfil their promise, they will revolutionise the pharmaceutical market far more fundamentally than the advent of biologic therapies in cancer and autoimmune disease in the 1990s and early 2000s. Disease areas will be transformed, and healthcare systems will need to re-design their approaches to provision of, and payment for treatments. The pharmaceutical companies making the right choices on the right assets have extraordinary commercial opportunities.
This white paper presents the case for revolutionizing research and development, and outlines new approaches to make clinical trials more cost effective and focused from start to finish.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Discover proven strategies and insights refined over more than 5,000 launches around the world.